{"count": 3, "results": [{"_id": "23583255", "pmid": 23583255, "title": "Simvastatin impairs exercise training adaptations.", "journal": "J Am Coll Cardiol", "authors": ["Mikus CR", "Boyle LJ", "Borengasser SJ", "Oberlin DJ", "Naples SP", "Fletcher J", "Meers GM", "Ruebel M", "Laughlin MH", "Dellsperger KC", "Fadel PJ", "Thyfault JP"], "date": "2013-08-20T00:00:00Z", "doi": "10.1016/j.jacc.2013.02.074", "meta_date_publication": "2013 Aug 20", "meta_volume": "62", "meta_issue": "8", "meta_pages": "709-14", "score": 50065.613, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuates increases in cardiorespiratory fitness and skeletal muscle mitochondrial content when combined with exercise training in @<m>DISEASE_Overweight</m> @DISEASE_MESH:D050177 @@@overweight@@@ or @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_9606 @@@patients@@@ at risk of the @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@. ", "citations": {"NLM": "Mikus CR, Boyle LJ, Borengasser SJ, Oberlin DJ, Naples SP, Fletcher J, Meers GM, Ruebel M, Laughlin MH, Dellsperger KC, Fadel PJ, Thyfault JP. Simvastatin impairs exercise training adaptations. J Am Coll Cardiol. 2013 Aug 20;62(8):709-14. PMID: 23583255", "BibTeX": "@article{23583255, title={Simvastatin impairs exercise training adaptations.}, author={Mikus CR and Boyle LJ and Borengasser SJ and Oberlin DJ and Naples SP and Fletcher J and Meers GM and Ruebel M and Laughlin MH and Dellsperger KC and Fadel PJ and Thyfault JP}, journal={J Am Coll Cardiol}, volume={62}, number={8}, pages={709-14}}"}}, {"_id": "20110160", "pmid": 20110160, "title": "A pilot comprehensive lifestyle intervention program (CLIP)--comparison with qualitative lifestyle advice and simvastatin on cardiovascular risk factors in overweight hypercholesterolaemic individuals.", "journal": "Nutr Metab Cardiovasc Dis", "authors": ["Cleanthous X", "Noakes M", "Brinkworth GD", "Keogh JB", "Williams G", "Clifton PM"], "date": "2011-03-01T00:00:00Z", "doi": "10.1016/j.numecd.2009.09.002", "meta_date_publication": "2011 Mar", "meta_volume": "21", "meta_issue": "3", "meta_pages": "165-72", "score": 50057.58, "text_hl": "A pilot comprehensive lifestyle intervention program (CLIP)--comparison with qualitative lifestyle advice and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on cardiovascular risk factors in @<m>DISEASE_Overweight</m> @DISEASE_MESH:D050177 @@@overweight@@@ hypercholesterolaemic individuals.", "citations": {"NLM": "Cleanthous X, Noakes M, Brinkworth GD, Keogh JB, Williams G, Clifton PM. A pilot comprehensive lifestyle intervention program (CLIP)--comparison with qualitative lifestyle advice and simvastatin on cardiovascular risk factors in overweight hypercholesterolaemic individuals. Nutr Metab Cardiovasc Dis. 2011 Mar;21(3):165-72. PMID: 20110160", "BibTeX": "@article{20110160, title={A pilot comprehensive lifestyle intervention program (CLIP)--comparison with qualitative lifestyle advice and simvastatin on cardiovascular risk factors in overweight hypercholesterolaemic individuals.}, author={Cleanthous X and Noakes M and Brinkworth GD and Keogh JB and Williams G and Clifton PM}, journal={Nutr Metab Cardiovasc Dis}, volume={21}, number={3}, pages={165-72}}"}}, {"_id": "28291866", "pmid": 28291866, "title": "Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.", "journal": "JAMA Cardiol", "authors": ["Giugliano RP", "Wiviott SD", "Blazing MA", "De Ferrari GM", "Park JG", "Murphy SA", "White JA", "Tershakovec AM", "Cannon CP", "Braunwald E"], "date": "2017-05-01T00:00:00Z", "doi": "10.1001/jamacardio.2017.0083", "meta_date_publication": "2017 May 1", "meta_volume": "2", "meta_issue": "5", "meta_pages": "547-555", "score": 50033.5, "text_hl": "@SPECIES_9606 @@@Patients@@@ with LDL-C values less than 30 mg/dL (median, 25 mg/dL; interquartile range, 21-27 mg/dL) at 1 month were more likely randomized to @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (85%), had lower baseline LDL-C values, and were more likely older, male, nonwhite, @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@, @<m>DISEASE_Overweight</m> @DISEASE_MESH:D050177 @@@overweight@@@, statin naive, and presenting with a first @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@. ", "citations": {"NLM": "Giugliano RP, Wiviott SD, Blazing MA, De Ferrari GM, Park JG, Murphy SA, White JA, Tershakovec AM, Cannon CP, Braunwald E. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial. JAMA Cardiol. 2017 May 1;2(5):547-555. PMID: 28291866", "BibTeX": "@article{28291866, title={Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.}, author={Giugliano RP and Wiviott SD and Blazing MA and De Ferrari GM and Park JG and Murphy SA and White JA and Tershakovec AM and Cannon CP and Braunwald E}, journal={JAMA Cardiol}, volume={2}, number={5}, pages={547-555}}"}}]}